BioNTech SE (BNTX)

[Man6677]

BioNTech Paves Way for Advanced mRNA-based Vaccines

Source: TipRanks
Biotechnology company BioNTech SE (NASDAQ: BNTX) recently revealed that it has joined hands with a fellow biotechnology company, Matinas BioPharma, to evaluate the combination of mRNA formats and Matinas’ proprietary LNC platform technology. Following the news, shares of the company rose marginally on Monday. The stock pared its gains completely and declined 2.5% to close at $166.28 in the extended trading session. The collaboration will leverage BioNTech’s expertise in mRNA vaccine development and Matinas’ proprietary LNC platform technology to advance novel formulations for mRNA vaccines, including a potential formulation for oral vaccines.
https://www.tipranks.com/news/biontech-paves-way-for-advanced-mrna-based-vaccines?utm_source=advfn.com&utm_medium=referral


BNTX $$$$